Downloads: 122
Research Paper | Medical Science | India | Volume 7 Issue 10, October 2018
Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
Dr. Kabita Bora Baishya [3] | Dr. Suprio Kumar Datta
Abstract: Diabetic retinopathy (DR) is the most common microvascular complication of diabetes. The most common cause of vision loss in diabetic retinopathy is diabetic macular edema. Intravitreal injection of corticosteroids (triamcinolone acetonide), constitutes a newer, less destructive treatment modality in the management of diabetic macular edema. . Intravitreal triamcinolone acetonide is a favourable and promising therapeutic tool in managing diffuse diabetic macular oedema for certain duration of time with minimal transient side effect.
Keywords: Diabetic macular edema, OCT, intravitreal triamcinolone acetonide
Edition: Volume 7 Issue 10, October 2018,
Pages: 915 - 919
Similar Articles with Keyword 'OCT'
Downloads: 0
Research Paper, Medical Science, Albania, Volume 11 Issue 12, December 2022
Pages: 68 - 75Ketoacidosis as the First Presentation of Type 1 Diabetes Mellitus in Children and Adolescents during the Period 2010-2014 in Albania
Laurant Kollcaku
Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Case Studies, Medical Science, India, Volume 11 Issue 2, February 2022
Pages: 410 - 412In World First Transplant; A Man Received Genetically-Modified Pig Heart
A. Pandey